Press Releases

Jun 09, 2025 7:00am EDT

COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

Jun 04, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

May 30, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

May 28, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

May 14, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS

Apr 15, 2025 8:00am EDT

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies

Mar 26, 2025 8:00am EDT

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE

Mar 19, 2025 7:00am EDT

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Feb 24, 2025 7:00am EST

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

Feb 12, 2025 6:00am EST

CollPlant Biotechnologies Provides a Corporate Update